Infantile haemangioma expresses embryonic stem cell markers

Journal of Clinical Pathology

Volumn 65, Issue 5, 2012, Pages 394-398

  Itinteang, Tinte ^a,b,c   Tan, Swee T ^a,b,c,d   Brasch, Helen D ^c   Steel, Ryan ^a   Best, Heather A ^a   Vishvanath, Anasuya ^a   Jia, Jun ^b   Day, Darren J ^a,b,c  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b GILLIES MCINDOE RESEARCH INSTITUTE   (New Zealand)

^c HUTT HOSPITAL   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 4; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY HEMANGIOMA; CELL POPULATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM; FUNCTIONAL STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFANT; LEYDIG CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SCID MOUSE; TERATOMA; TUMOR BIOPSY; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; CELL PROLIFERATION; CHILD; EMBRYONIC STEM CELLS; GENE EXPRESSION; HEMANGIOMA; HUMANS; INFANT; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; OCTAMER TRANSCRIPTION FACTOR-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STAT3 TRANSCRIPTION FACTOR; TERATOMA; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860735926     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200462     Document Type: Article

References (25)

1. Tan ST, Velickovic M, Ruger BM, et al. Cellular and extracellular markers of hemangioma. Plast Reconstr Surg 2000;106:529-38. (Pubitemid 30666290)
2. Frieden IJ, Eichenfield LF, Esterly NB, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997;37:631-7.
3. Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:357-64.
4. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg 2011;64:292-9.
5. Itinteang T, Withers AH, Leadbitter P, et al. Pharmacologic therapies for infantile hemangioma: is there rational basis? Plast Reconstr Surg 2011;128:499-507.
6. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics 2011;127:e772-6.
7. Itinteang T, Tan ST, Brasch H, et al. Primitive mesodermal cells with a neural crest stem cell phenotype predominate proliferating infantile haemangioma. J Clin Pathol 2010;63:771-6.
8. Itinteang T, Tan ST, Brasch H, et al. Haemogenic endothelium in infantile haemangioma. J Clin Pathol 2010;63:982-6.
9. Itinteang T, Tan ST, Brasch HD, et al. Primitive erythropoiesis in infantile haemangioma. Br J Dermatol 2011;164:1097-100.
10. Itinteang T, Vishvanath A, Day DJ, et al. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol 2011;64:232-6.
11. Itinteang T, Brasch HD, Tan ST, et al. Expression of components of the renineangiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution. J Plast Reconstr Aesthet Surg 2011;64:759-5.
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cells lines derived from human blastocysts. Science 1998;282:1145-7. (Pubitemid 28516247)
13. Laslett AL, Filipczyk AA, Pera MF. Characterization and culture of human embryonic stem cells. Trends Cardiovasc Med 2003;13:295-301. (Pubitemid 37159395)
14. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the pou transcription factor Oct4. Cell 1998;95:379-91. (Pubitemid 28507326)
15. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002;12:432-8. (Pubitemid 35239952)
16. Brimble SN, Sherrer ES, Uhl EW, et al. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells 2007;25:54-62. (Pubitemid 46052974)
17. Rodda DJ, Chew JL, Lim LH, et al. Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 2005;280:24731-7. (Pubitemid 40934562)
18. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotech 2001;19:971-4. (Pubitemid 32947578)
19. Kennedy M, D'Souza SL, Lynch-Kattman M, et al. Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood 2007;109:2679-87. (Pubitemid 46482058)
20. Avery S, Zafarana G, Gokhale PJ, et al. The role of SMAD4 in human embryonic stem cell self-renewal and stem cell fate. Stem Cells 2010;28:863-73.
21. Williams RL, Risau W, Zerwes HG, et al. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989;57:1053-63. (Pubitemid 19168385)
22. North PE, Milton W, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22. (Pubitemid 30054381)
23. Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008;118:2592-9. (Pubitemid 351949786)
24. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-19.
25. Itinteang T, Tan ST, Guthrie G, et al. A placental chorionic villous mesenchymal core cellular origin for infantile haemangioma. J Clin Pathol 2011;64:870-4.